New Drug for Chronic Heart FailureAschenbrenner, Diane S. MS, RNAJN, American Journal of Nursing: August 2015 - Volume 115 - Issue 8 - p 48,49 doi: 10.1097/01.NAJ.0000470403.74424.20 Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics Ivabradine (Corlanor) is a new drug used in the treatment of stabilized chronic heart failure. It decreases the risks of worsening heart failure and hospitalization. Ivabradine is contraindicated if there is an acute exacerbation of heart failure, hypotension, or various cardiac pathologies that alter the generation of a heartbeat or the conductivity of the electrical charge within the heart. The most common adverse effects are bradycardia, hypertension, atrial fibrillation, and temporary vision disturbances characterized by flashes of light (known as phosphenes). Diane S. Aschenbrenner was previously the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:firstname.lastname@example.org. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.